Pharmaceutical Executive

Pharmaceutical Executive-01-01-2021
Volume: 41
Issue: 1

Pharmaceutical Executive-12-01-2020
Volume: 40
Issue: 12

Pharmaceutical Executive-11-01-2020
Volume: 40
Issue: 11

Pharmaceutical Executive-10-01-2020
Volume: 40
Issue: 10

Pharmaceutical Executive-09-01-2020
Volume: 40
Issue: 9

Pharmaceutical Executive-08-01-2020
Volume: 40
Issue: 8

Pharmaceutical Executive-07-01-2020
Volume: 40
Issue: 7

Pharmaceutical Executive-06-01-2020
Volume: 40
Issue: 6

Pharmaceutical Executive-05-01-2020
Volume: 40
Issue: 5

Pharmaceutical Executive-04-01-2020
Volume: 40
Issue: 4

Pharmaceutical Executive-03-01-2020
Volume: 40
Issue: 3

Pharmaceutical Executive-02-01-2020
Volume: 40
Issue: 2

Pharmaceutical Executive-01-01-2020
Volume: 40
Issue: 1

Pharmaceutical Executive-12-01-2019
Volume: 39
Issue: 12

Pharmaceutical Executive-11-01-2019
Volume: 39
Issue: 11

Pharmaceutical Executive-10-01-2019
Volume: 39
Issue: 10

Pharmaceutical Executive-09-01-2019
Volume: 39
Issue: 9

Pharmaceutical Executive-08-01-2019
Volume: 39
Issue: 8

Pharmaceutical Executive-07-01-2019
Volume: 39
Issue: 7

Pharmaceutical Executive-06-01-2019
Volume: 39
Issue: 6

Pharmaceutical Executive-05-01-2019
Volume: 39
Issue: 5

Pharmaceutical Executive-04-01-2019
Volume: 39
Issue: 4

Pharmaceutical Executive-03-01-2019
Volume: 39
Issue: 3

Pharmaceutical Executive-02-01-2019
Volume: 39
Issue: 2

Pharmaceutical Executive-01-01-2019
Volume: 39
Issue: 1

Pharmaceutical Executive-12-01-2018
Volume: 38
Issue: 12

Pharmaceutical Executive-11-01-2018
Volume: 38
Issue: 11

Pharmaceutical Executive-10-01-2018
Volume: 38
Issue: 10

Pharmaceutical Executive-09-01-2018
Volume: 38
Issue: 9

Pharmaceutical Executive-08-01-2018
Volume: 38
Issue: 8
Advertisement
Advertisement
Trending on PharmExec
1
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
2
Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report
3
BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies
4
The Science of Targeting Multiple Immune Components in ITP: Q&A with Dr. Srikanth Nagalla
5
